Advert - AstraZeneca UK Limited – Case AUTH/3430/11/20
Promotion of unlicensed Covid-19 Vaccine on LinkedIn
-
Date posted16 March 2022
-
SanctionAdvertisement,
-
Case number/s
For promoting an unlicensed vaccine, including to members of the UK public on LinkedIn, AstraZeneca was ruled in breach of the following clauses of the 2019 Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 3.1 - Promoting an unlicensed medicine
Clause 9.1 - Failing to maintain high standards